Developed in collaboration with Chronicle Bio and its CEO Rohit Gupta, the platform will enable a deeper understanding of disease biology to drive earlier diagnoses, more effective treatments, and lasting benefits for patients and humanity
Developed in collaboration with Chronicle Bio and its CEO Rohit Gupta, the platform will enable a deeper understanding of disease biology to drive earlier diagnoses, more effective treatments, and lasting benefits for patients and humanity